Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus

• Main Authors: Noël Zahr (Author), Saik Urien (Author), Christian Funck-Brentano (Author), Hélène Vantomme (Author), Nicolas Garcelon (Author), Isabelle Melki (Author), Margaux Boistault (Author), Olivia Boyer (Author), Brigitte Bader-Meunier (Author)
• Format: Book
• Published: MDPI AG, 2021-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Hydroxychloroquine (HCQ) is an antimalarial agent given to patients with systemic lupus erythematosus (SLE) as first-line therapy. It alleviates childhood-onset systemic lupus erythematosus cSLE skin and musculoskeletal disease, decreasing disease activity and flares. HCQ concentration-e...